Related Experiment Video
Updated: Feb 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Relationships of kidney injury molecule-1 with renal function and cardiovascular risk factors in the general
Peter Egli1, Stefanie Aeschbacher1, Matthias Bossard2
1Cardiovascular Research Institute Basel, University Hospital Basel, University of Basel, Basel, Switzerland; Division of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.
Insights
Kidney injury molecule-1 (KIM-1) in healthy adults showed no link to kidney function but was associated with cardiovascular risk factors like blood pressure and cholesterol.
Area of Science:
- Nephrology
- Cardiology
- Biomarker Research
Background:
- Kidney injury molecule-1 (KIM-1) is linked to kidney damage in patients with existing renal disease.
- Limited data exists on KIM-1's association with renal function and cardiovascular risk in healthy general populations.
Purpose of the Study:
- To investigate the relationship between plasma KIM-1 levels and renal function in healthy adults.
- To assess the association of KIM-1 with cardiovascular risk factors in a general healthy population.
Main Methods:
- A population-based study included 2060 healthy adults aged 25-41 years.
- Exclusion criteria included high BMI, pre-existing kidney or cardiovascular disease.
- Plasma KIM-1 was measured using a high-sensitivity assay; multivariable linear regression analyzed associations.
Main Results:
- No significant relationship was found between KIM-1 and creatinine or cystatin C.
- Plasma KIM-1 levels showed significant linear relationships with systolic and diastolic blood pressure.
- KIM-1 was also associated with LDL cholesterol, HDL cholesterol, hs-CRP, age, BMI, and smoking status.
Conclusions:
- In healthy adults, plasma KIM-1 is not associated with renal function.
- Plasma KIM-1 is independently related to multiple cardiovascular risk factors in the general population.
Background:
Kidney injury molecule-1 (KIM-1) has been associated with kidney damage in patients with preexisting renal disease. However, little is known about the relationships of KIM-1 with renal function and cardiovascular risk factors in healthy individuals from the general population.
Methods:
Healthy individuals aged 25-41years were enrolled in a population-based study. Main exclusion criteria were a BMI >35kg/m2, preexisting kidney disease or established cardiovascular disease. KIM-1 was measured from frozen plasma samples using a high-sensitivity assay. Multivariable linear regression models were constructed to assess the relationships of KIM-1 with renal function and various cardiovascular risk factors.
Results:
We included 2060 individuals (47% men, median (interquartile range) age: 37 (31-40) years) in this analysis. Median KIM-1 levels were 82.5 (IQR 59.4-112.7) pg/ml. We found no significant relationship of KIM-1 with creatinine (adjusted β-coefficient (95% confidence interval) 0.0005 (-0.002; 0.003), p=0.61) and cystatin C (-0.02 (-0.21; 0.17), p=0.84). There were significant linear relationships of log-transformed KIM-1 with systolic blood pressure (adjusted β-coefficient (95% confidence interval) 0.07 (0.04; 0.09), p<0.0001), diastolic blood pressure (0.04 (0.02; 0.07), p=0.001), low-density lipoprotein cholesterol (0.09 (0.06; 0.11), p<0.0001), high-density lipoprotein cholesterol (0.07 (0.05; 0.1), p<0.0001), high-sensitivity C-reactive protein (0.05 (0.03; 0.07), p<0.0001), age (0.09 (0.07; 0.11), p<0.0001), BMI (0.04 (0.01; 0.06), p=0.005) and current smoking (0.12 (0.07; 0.17), p<0.0001).
Conclusion:
Among healthy adults from the general population, plasma levels of KIM-1 were not associated with renal function but were independently related to multiple cardiovascular risk factors.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations

